The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictive and prognostic features of metastatic colorectal cancer arising from the transverse colon: A pooled analysis of the CCTG/AGITG CO.17 and CO.20 randomized trials.
 
Joao Paulo Solar Vasconcelos
Honoraria - MSD/Merck
Consulting or Advisory Role - Merck; MSD/Merck
Travel, Accommodations, Expenses - Astellas Oncology; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen; Merck; MSD/Merck; Novartis; Roche
 
Nan Chen
No Relationships to Disclose
 
Dongsheng Tu
No Relationships to Disclose
 
Stephanie Yasmin Brule
No Relationships to Disclose
 
Rachel Anne Goodwin
Honoraria - Advanced Accelerator Applications; Eisai; Ipsen; Pfizer
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Amgen; Apobiologix; Astellas Pharma; AstraZeneca Canada; Eisai; Incyte; Ipsen; Merck; MSD; Novartis; Novartis; Pfizer; Roche Canada; Taiho Pharmaceutical; Viatris
Speakers' Bureau - Advanced Accelerator Applications/Novartis; Amgen; Eisai; Ipsen; Merck; Mylan; Pfizer
Research Funding - Eisai; Ipsen
 
Derek J. Jonker
No Relationships to Disclose
 
Timothy Jay Price
Honoraria - SERVIER
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); BMS (Inst); Merck
Research Funding - AMGEN (Inst)
Travel, Accommodations, Expenses - Amgen
 
John Raymond Zalcberg
Leadership - ICON Group; Lipotek
Stock and Other Ownership Interests - Amarin Corporation; Biomarin; Concert Pharmaceuticals; Frequency Therapeutics; Gilead Sciences; Madrigal Pharmaceuticals; Moderna Therapeutics; Novavax; Opthea; Orphazyme; Twist Bioscience; UniQure; Zogenix
Honoraria - Deciphera; Gilead Sciences; Halozyme; Merck Serono; MSD Oncology; Specialised Therapeutics; Targovax; Viatris
Consulting or Advisory Role - 1Globe Health Institute; Alloplex Biotherapeutics Inc; Center for Emerging & Neglected Diseases (CEND); Deciphera; FivePHusion; Genor BioPharma; Lisata; Merck Sharp & Dohme; NOUS Group; Novotech; Revolution Medicines; Specialised Therapeutics
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Ipsen (Inst); IQvia (Inst); Medtronic (Inst); MSD Oncology (Inst); Mylan (Inst); Pfizer (Inst)
 
Malcolm J. Moore
No Relationships to Disclose
 
Christos Stelios Karapetis
No Relationships to Disclose
 
Lillian L. Siu
Leadership - Treadwell Therapeutics (I)
Stock and Other Ownership Interests - Agios (I)
Consulting or Advisory Role - Amgen; Arvinas; AstraZeneca/MedImmune; Daiichi Sankyo/UCB Japan; GlaxoSmithKline; Hookipa Pharma; InterRNA; Janpix; Janssen; Merck; Navire; Oncorus; Relay Therapeutics; Roche; Sanofi; Seagen; Tessa Therapeutics; Voronoi Health Analytics
Research Funding - Amgen (Inst); Amgen (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AVID Radiopharmaceuticals (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Intensity Therapeutics (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Shattuck Labs (Inst); Symphogen (Inst)
 
Jeremy David Shapiro
No Relationships to Disclose
 
John Simes
Consulting or Advisory Role - FivePhusion (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Elevation Oncology (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)
 
Christopher J. O'Callaghan
No Relationships to Disclose
 
Jonathan M. Loree
Consulting or Advisory Role - AMGEN; Bayer; Eisai; Ipsen; Novartis; Pfizer; Taiho Pharmaceutical
Research Funding - Amgen (Inst); Ipsen (Inst)